Skip to search formSkip to main contentSkip to account menu

Poractant alfa

Known as: fractions phospholipid, poractant, poractant alfa [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

9 relations
AtelectasisPoractant alfa 80 MG/ML Intratracheal SuspensionPoractant alfa 80 MG/ML Intratracheal Suspension [Curosurf]Respiratory Distress Syndrome, Newborn

Broader (3)

Biological ProductsPhospholipidsPulmonary Surfactants

Narrower (1)

Curosurf

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome
Objective CHF5633 (Chiesi Farmaceutici S.p.A., Parma, Italy) is the first fully synthetic surfactant enriched by peptide… 
Review
2015
Review
2015
Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study
Purpose To compare the efficacy of the new drug calfactant with the commonly used drugs surfactant-TA and poractant alfa… 
Highly Cited
2014
Highly Cited
2014
The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation
BackgroundIt is now recognized that preterm infants ≤28 weeks gestation can be effectively supported from the outset with nasal… 
Review
2011
Review
2011
Efficacy of Porcine Versus Bovine Surfactants for Preterm Newborns With Respiratory Distress Syndrome: Systematic Review and Meta-analysis
OBJECTIVE: To compare the efficacy of a porcine surfactant (poractant alfa) versus bovine surfactants (beractant and calfactant… 
Review
2011
Review
2011
Surfactant Replacement Therapy in Preterm Infants: A European Survey
Background: Exogenous surfactant is an undisputed treatment for neonatal respiratory distress syndrome but its efficacy is highly… 
2010
2010
Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome
Objective:Comparison of the differences between availability of animal-derived surfactant preparations used to treat premature… 
Review
2010
Review
2010
Different Effects of Surfactant Proteins B and C – Implications for Development of Synthetic Surfactants
Treatment of premature newborn rabbits with synthetic surfactants containing a surfactant protein C analogue in a simple… 
2009
2009
Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
Introduction: Available literature suggests that the advantage of animal-derived surfactants over first-generation synthetic… 
Review
2005
Review
2005
History of Surfactant from 1980
The first successful trial of surfactant treatment for respiratory distress syndrome (RDS) was reported in 1980. Since then there… 
Highly Cited
2000
Highly Cited
2000
Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25–29 weeks' gestation: a randomised trial
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)